ROC curve analyses indicated that the AUC values of CCR1 and CD163 were above 0.7 in all of the four datasets, indicating that CCR1 and CD163 had a good diagnostic capacity for HF and NAFLD (Figures 5E–H). This evidence concerns the gene CD163 and metabolic dysfunction-associated steatotic liver disease.